Study ID: C10953/1100 | 2012-005510-20

Study Title

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Teva Identifier

C10953/1100 | 2012-005510-20

ClinicalTrials.gov Identifier

NCT01624480

Study Status

Completed

Trial Condition(s)

Narcolepsy

Interventions

Drug: Armodafinil

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

6 Years to 17 Years

Trial Duration

07/01/2012 - 12/01/2015

Phase

Phase 1

Study Type

Interventional